{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:32:37Z","timestamp":1787311957614,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China","award":["LHDMZ24H160002"],"award-info":[{"award-number":["LHDMZ24H160002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02511-x","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:02:05Z","timestamp":1727715725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"21","author":[{"given":"Jintao","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genyong","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2511_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The, \u201csilent\u201d global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26:86\u2013102. https:\/\/doi.org\/10.1128\/CMR.00062-12.","journal-title":"Clin Microbiol Rev"},{"key":"2511_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","volume":"122","author":"ML Green","year":"2013","unstructured":"Green ML, et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood. 2013;122:1316\u201324. https:\/\/doi.org\/10.1182\/blood-2013-02-487074.","journal-title":"Blood"},{"key":"2511_CR3","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","volume":"127","author":"P Teira","year":"2016","unstructured":"Teira P, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127:2427\u201338. https:\/\/doi.org\/10.1182\/blood-2015-11-679639.","journal-title":"Blood"},{"key":"2511_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","volume":"16","author":"N Cantoni","year":"2010","unstructured":"Cantoni N, et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16:1309\u201314. https:\/\/doi.org\/10.1016\/j.bbmt.2010.03.020.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2511_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/ajh.25214","volume":"93","author":"EH Estey","year":"2018","unstructured":"Estey EH. Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol. 2018;93:1267\u201391. https:\/\/doi.org\/10.1002\/ajh.25214.","journal-title":"Am J Hematol"},{"key":"2511_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ajh.26270","volume":"96","author":"JM Zain","year":"2021","unstructured":"Zain JM, Hanona P. Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk stratification and management. Am J Hematol. 2021;96:1027\u201346. https:\/\/doi.org\/10.1002\/ajh.26270.","journal-title":"Am J Hematol"},{"key":"2511_CR7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ajh.25950","volume":"95","author":"G Garcia-Manero","year":"2020","unstructured":"Garcia-Manero G, Chien KS, Montalban-Bravo G. Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management. Am J Hematol. 2020;95:1399\u2013420. https:\/\/doi.org\/10.1002\/ajh.25950.","journal-title":"Am J Hematol"},{"key":"2511_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/jix357","volume":"216","author":"XY Pei","year":"2017","unstructured":"Pei XY, et al. Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus. J Infect Dis. 2017;216:945\u201356. https:\/\/doi.org\/10.1093\/infdis\/jix357.","journal-title":"J Infect Dis"},{"key":"2511_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1182\/blood-2018-10-878918","volume":"133","author":"JF Camargo","year":"2019","unstructured":"Camargo JF, et al. Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation. Blood. 2019;133:867\u201377. https:\/\/doi.org\/10.1182\/blood-2018-10-878918.","journal-title":"Blood"},{"key":"2511_CR10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.21873\/anticanres.16947","volume":"44","author":"L Alkassab","year":"2024","unstructured":"Alkassab L, et al. TCR CDR3-CMV antigen chemical complementaries are associated with a worse outcome for renal cell carcinoma. Anticancer Res. 2024;44:1505\u201311. https:\/\/doi.org\/10.21873\/anticanres.16947.","journal-title":"Anticancer Res"},{"key":"2511_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031029","author":"L Bunse","year":"2022","unstructured":"Bunse L, et al. Common T-cell-receptor motifs and features in patients with cytomegalovirus (CMV)-seronegative end-stage renal disease receiving a peptide vaccination against CMV. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031029.","journal-title":"Int J Mol Sci"},{"key":"2511_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf4001","author":"MN Lee","year":"2021","unstructured":"Lee MN, Meyerson M. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells. Sci Immunol. 2021. https:\/\/doi.org\/10.1126\/sciimmunol.abf4001.","journal-title":"Sci. Immunol."},{"key":"2511_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41375-019-0654-y","volume":"34","author":"S Buhler","year":"2020","unstructured":"Buhler S, et al. Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation. Leukemia. 2020;34:1422\u201332. https:\/\/doi.org\/10.1038\/s41375-019-0654-y.","journal-title":"Leukemia"},{"key":"2511_CR14","doi-asserted-by":"publisher","first-page":"679130","DOI":"10.3389\/fmolb.2021.679130","volume":"8","author":"J Sheng","year":"2021","unstructured":"Sheng J, et al. Deep sequencing of T-cell receptors for monitoring peripheral CD8(+) T cells in chinese advanced non-small-cell lung cancer patients treated with the anti-PD-L1 antibody. Front Mol Biosci. 2021;8:679130. https:\/\/doi.org\/10.3389\/fmolb.2021.679130.","journal-title":"Front Mol Biosci"},{"key":"2511_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00262-020-02738-x","volume":"70","author":"H Jiang","year":"2021","unstructured":"Jiang H, et al. Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study. Cancer Immunol Immunother. 2021;70:857\u201368. https:\/\/doi.org\/10.1007\/s00262-020-02738-x.","journal-title":"Cancer Immunol Immunother"},{"key":"2511_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bbmt.2019.10.026","volume":"26","author":"X Gao","year":"2020","unstructured":"Gao X, et al. Quantitative analysis of thymus-independent donor-derived T cell expansion in transplant patients. Biol Blood Marrow Transplant. 2020;26:242\u201353. https:\/\/doi.org\/10.1016\/j.bbmt.2019.10.026.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2511_CR17","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/s41409-019-0625-y","volume":"54","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy. Bone Marrow Transplant. 2019;54:2072\u201380. https:\/\/doi.org\/10.1038\/s41409-019-0625-y.","journal-title":"Bone Marrow Transplant"},{"key":"2511_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1182\/bloodadvances.2019000814","volume":"4","author":"S Kaito","year":"2020","unstructured":"Kaito S, et al. Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation. Blood Adv. 2020;4:1051\u201361. https:\/\/doi.org\/10.1182\/bloodadvances.2019000814.","journal-title":"Blood Adv"},{"key":"2511_CR19","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1093\/infdis\/jiz389","volume":"221","author":"AC Hodowanec","year":"2020","unstructured":"Hodowanec AC, Pikis A, Singer ME. The development of therapeutics for the treatment and prevention of CMV disease in the transplant population: a regulatory perspective. J Infect Dis. 2020;221:S109\u201312. https:\/\/doi.org\/10.1093\/infdis\/jiz389.","journal-title":"J Infect Dis"},{"key":"2511_CR20","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/ajt.15764","volume":"20","author":"FM Marty","year":"2020","unstructured":"Marty FM, et al. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. Am J Transplant. 2020;20:1703\u201311. https:\/\/doi.org\/10.1111\/ajt.15764.","journal-title":"Am J Transplant"},{"key":"2511_CR21","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1302064","volume":"192","author":"OV Britanova","year":"2014","unstructured":"Britanova OV, et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol. 2014;192:2689\u201398. https:\/\/doi.org\/10.4049\/jimmunol.1302064.","journal-title":"J Immunol"},{"key":"2511_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1159\/000445656","volume":"39","author":"X Hou","year":"2016","unstructured":"Hou X, et al. Analysis of the repertoire features of TCR beta chain CDR3 in human by high-throughput sequencing. Cell Physiol Biochem. 2016;39:651\u201367. https:\/\/doi.org\/10.1159\/000445656.","journal-title":"Cell Physiol Biochem"},{"key":"2511_CR23","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","volume":"125","author":"Y Suessmuth","year":"2015","unstructured":"Suessmuth Y, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRbeta repertoire. Blood. 2015;125:3835\u201350. https:\/\/doi.org\/10.1182\/blood-2015-03-631853.","journal-title":"Blood"},{"key":"2511_CR24","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41409-021-01354-2","volume":"56","author":"JA Kuzich","year":"2021","unstructured":"Kuzich JA, et al. T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection. Bone Marrow Transplant. 2021;56:2582\u201390. https:\/\/doi.org\/10.1038\/s41409-021-01354-2.","journal-title":"Bone Marrow Transplant"},{"key":"2511_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.03.072","volume":"19","author":"G Chen","year":"2017","unstructured":"Chen G, et al. Sequence and structural analyses reveal distinct and highly diverse human CD8(+) TCR repertoires to immunodominant viral antigens. Cell Rep. 2017;19:569\u201383. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.072.","journal-title":"Cell Rep"},{"key":"2511_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00974-17","author":"Y Ishihara","year":"2017","unstructured":"Ishihara Y, et al. A unique T-cell receptor amino acid sequence selected by human T-cell lymphotropic virus type 1 Tax301\u2013309-specific cytotoxic T cells in HLA-A24:02-positive asymptomatic carriers and adult T-Cell leukemia\/lymphoma patients. J Virol. 2017. https:\/\/doi.org\/10.1128\/JVI.00974-17.","journal-title":"J Virol"},{"key":"2511_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ng.3822","volume":"49","author":"RO Emerson","year":"2017","unstructured":"Emerson RO, et al. Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire. Nat Genet. 2017;49:659\u201365. https:\/\/doi.org\/10.1038\/ng.3822.","journal-title":"Nat Genet"},{"key":"2511_CR28","doi-asserted-by":"publisher","first-page":"285ra263","DOI":"10.1126\/scitranslmed.aaa2546","volume":"7","author":"PJ Hanley","year":"2015","unstructured":"Hanley PJ, et al. CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015;7:285ra263. https:\/\/doi.org\/10.1126\/scitranslmed.aaa2546.","journal-title":"Sci Transl Med"},{"key":"2511_CR29","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.4049\/jimmunol.1303147","volume":"192","author":"TH Nguyen","year":"2014","unstructured":"Nguyen TH, et al. Recognition of distinct cross-reactive virus-specific CD8+ T cells reveals a unique TCR signature in a clinical setting. J Immunol. 2014;192:5039\u201349. https:\/\/doi.org\/10.4049\/jimmunol.1303147.","journal-title":"J Immunol"},{"key":"2511_CR30","doi-asserted-by":"publisher","first-page":"e1002889","DOI":"10.1371\/journal.ppat.1002889","volume":"8","author":"PL Klarenbeek","year":"2012","unstructured":"Klarenbeek PL, et al. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog. 2012;8:e1002889. https:\/\/doi.org\/10.1371\/journal.ppat.1002889.","journal-title":"PLoS Pathog"},{"key":"2511_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/bmt.2013.122","volume":"49","author":"H Nakasone","year":"2014","unstructured":"Nakasone H, et al. Single-cell T-cell receptor-beta analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:87\u201394. https:\/\/doi.org\/10.1038\/bmt.2013.122.","journal-title":"Bone Marrow Transplant"},{"key":"2511_CR32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.molimm.2006.06.026","volume":"44","author":"P Miqueu","year":"2007","unstructured":"Miqueu P, et al. Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol. 2007;44:1057\u201364. https:\/\/doi.org\/10.1016\/j.molimm.2006.06.026.","journal-title":"Mol Immunol"},{"key":"2511_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.13247","volume":"196","author":"L Werner","year":"2019","unstructured":"Werner L, et al. Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitis. Clin Exp Immunol. 2019;196:1\u201311. https:\/\/doi.org\/10.1111\/cei.13247.","journal-title":"Clin Exp Immunol"},{"key":"2511_CR34","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","volume":"114","author":"HS Robins","year":"2009","unstructured":"Robins HS, et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood. 2009;114:4099\u2013107. https:\/\/doi.org\/10.1182\/blood-2009-04-217604.","journal-title":"Blood"},{"key":"2511_CR35","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s42003-021-02709-7","volume":"4","author":"H Nakasone","year":"2021","unstructured":"Nakasone H, et al. Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation. Commun Biol. 2021;4:1177. https:\/\/doi.org\/10.1038\/s42003-021-02709-7.","journal-title":"Commun Biol"},{"key":"2511_CR36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/brain\/awh119","volume":"127","author":"DA Laplaud","year":"2004","unstructured":"Laplaud DA, et al. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution. Brain. 2004;127:981\u201395. https:\/\/doi.org\/10.1093\/brain\/awh119.","journal-title":"Brain"},{"key":"2511_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.gpb.2016.10.003","volume":"14","author":"Y Tong","year":"2016","unstructured":"Tong Y, et al. T cell repertoire diversity is decreased in type 1 diabetes patients. Genom Proteom Bioinf. 2016;14:338\u201348. https:\/\/doi.org\/10.1016\/j.gpb.2016.10.003.","journal-title":"Genom Proteom Bioinf"},{"key":"2511_CR38","doi-asserted-by":"publisher","first-page":"22218","DOI":"10.1038\/s41598-020-79363-2","volume":"10","author":"T Toya","year":"2020","unstructured":"Toya T, et al. T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation. Sci Rep. 2020;10:22218. https:\/\/doi.org\/10.1038\/s41598-020-79363-2.","journal-title":"Sci Rep"},{"key":"2511_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.virusres.2014.03.027","volume":"188","author":"A Liu","year":"2014","unstructured":"Liu A, et al. Preliminary exploration of HLA-A 1101-restricted human cytomegalovirus glycoprotein B-specific CD8(+) T cells in allogeneic stem-cell transplant recipients. Virus Res. 2014;188:38\u201344. https:\/\/doi.org\/10.1016\/j.virusres.2014.03.027.","journal-title":"Virus Res"},{"key":"2511_CR40","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/2211-5463.12690","volume":"9","author":"K Yu","year":"2019","unstructured":"Yu K, Shi J, Lu D, Yang Q. Comparative analysis of CDR3 regions in paired human alphabeta CD8 T cells. FEBS Open Bio. 2019;9:1450\u20139. https:\/\/doi.org\/10.1002\/2211-5463.12690.","journal-title":"FEBS Open Bio"},{"key":"2511_CR41","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bmt.2015.133","volume":"50","author":"PY Yew","year":"2015","unstructured":"Yew PY, et al. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015;50:1227\u201334. https:\/\/doi.org\/10.1038\/bmt.2015.133.","journal-title":"Bone Marrow Transplant"},{"key":"2511_CR42","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.bbmt.2020.04.026","volume":"26","author":"M Leick","year":"2020","unstructured":"Leick M, et al. t cell clonal dynamics determined by high-resolution TCR-beta sequencing in recipients after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2020;26:1567\u201374. https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.026.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02511-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02511-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02511-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:03:47Z","timestamp":1727715827000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02511-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02511-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University under protocol number 2019-484 on 25 February 2019. Consent was obtained in writing after providing participants with detailed information about the study\u2019s purpose, procedures, and potential risks.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}